| OTC Markets: NGSX
NeurogesX, Inc. is a biopharmaceutical company, which is focused on developing and commercializing a portfolio of novel non-opioid, pain management therapies to address unmet medical needs. Its product Qutenza, a synthetic capsaicin-based dermal patch designed to manage pain associated with peripheral neuropathic pain conditions. The company was formerly known as Advanced Analgesics, Inc. and changed its name to NeurogesX, Inc. in September 2000. NeurogesX was founded by Wendye R. Robbins on May 28, 1998 and is headquartered in San Mateo, CA.